Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.930
-0.310 (-7.31%)
At close: Jan 30, 2025, 4:00 PM
3.800
-0.130 (-3.31%)
After-hours: Jan 30, 2025, 6:44 PM EST
Vivos Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.30
Upside
+60.31%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $6.6 | Strong Buy | Reiterates | $6.6 | +67.94% | Nov 20, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $8.25 → $6 | Strong Buy | Maintains | $8.25 → $6 | +52.67% | Nov 19, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.4 → $6.6 | Strong Buy | Maintains | $6.4 → $6.6 | +67.94% | Aug 20, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +1,490.33% | Jan 17, 2023 |
| Roth Capital | Roth Capital | Strong Buy Maintains $275 → $250 | Strong Buy | Maintains | $275 → $250 | +6,261.32% | Aug 13, 2021 |
| Roth Capital | Roth Capital | Strong Buy Maintains $300 → $275 | Strong Buy | Maintains | $300 → $275 | +6,897.46% | May 18, 2021 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +7,533.59% | Jan 11, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $300 | Strong Buy | Initiates | $300 | +7,533.59% | Jan 5, 2021 |